This study looks at how well intismeran autogene and pembrolizumab work together compared to a placebo and pembrolizumab for people with non-small cell lung cancer that has been completely removed by surgery. The goal is to see if this combination helps keep the cancer from coming back after treatment.
The trial's ID number is NCT06077760. This is a Phase 3 study, which means it is looking at how well the treatment works and how safe it is. It is regulated by the FDA, and about 868 participants are expected to join.
Who can join
Adults aged 18 and older can join. This study is open to all genders. Participants must have had surgery for non-small cell lung cancer and must not have any signs of cancer before joining. The trial team will confirm who is eligible to participate.
Condition
Non-small Cell Lung Cancer
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants are randomly placed into two groups. One group will receive intismeran autogene along with pembrolizumab. The other group will receive a placebo with pembrolizumab. Everyone in the trial will receive treatment for about a year unless their cancer comes back or they have side effects.
Where
This trial is enrolling at 68 locations. Recruiting sites are listed first.
AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0013)
Orlando, Florida
Recruiting
Alaska Oncology and Hematology ( Site 0039)
Anchorage, Alaska
Recruiting
Altru Health System ( Site 0040)
Grand Forks, North Dakota
Recruiting
Atlantic Health Morristown Medical Center ( Site 4018)
Morristown, New Jersey
Recruiting
Baptist Cancer Center ( Site 4049)
Memphis, Tennessee
Recruiting
Cancer and Hematology Centers of Western Michigan ( Site 4003)
Chief of Thoracic Surgery and Director of the Lung Cancer Program at West Virginia University Cancer Institute. Treats lung cancer and esophageal cancer.
Treats pancreatic cancer, lung cancer and colorectal cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Led the National Lung Screening Trial. Treats lung cancer. Other doctors who help with cancer care, like gastroenterologists, dermatologists, and endocrinologists. Recognized at state, national or international level.